{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:29:16Z","timestamp":1773901756420,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T00:00:00Z","timestamp":1368403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T00:00:00Z","timestamp":1368403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1038\/bmt.2013.70","type":"journal-article","created":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T10:40:19Z","timestamp":1368441619000},"page":"1429-1436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Comorbidity burden in patients with chronic GVHD"],"prefix":"10.1038","volume":"48","author":[{"given":"W A","family":"Wood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Weisdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P J","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S Z","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Pidala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Jagasia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Storer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,13]]},"reference":[{"key":"BFbmt201370_CR1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1182\/blood.V100.2.406","volume":"100","author":"SJ Lee","year":"2002","unstructured":"Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002; 100: 406\u2013414.","journal-title":"Blood"},{"key":"BFbmt201370_CR2","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1182\/blood-2010-11-319509","volume":"117","author":"J Pidala","year":"2011","unstructured":"Pidala J, Kurland B, Chai X, Majhail N, Weisdorf DJ, Pavletic S et al. Patient reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD consortium. Blood 2011; 117: 4651\u20134657.","journal-title":"Blood"},{"key":"BFbmt201370_CR3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945\u2013956.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201370_CR4","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.bbmt.2011.05.007","volume":"17","author":"Chronic GVHD Consortium","year":"2011","unstructured":"Chronic GVHD Consortium. Rationale and design of the Chronic GVHD Cohort Study: improving outcomes assessment in chronic GVHD. Biol Blood Marrow Transplant 2011; 17: 1114\u20131120.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201370_CR5","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1182\/blood-2011-03-344390","volume":"118","author":"S Arai","year":"2011","unstructured":"Arai S, Jagasia M, Storer B, Chai X, Pidala J, Cutler C et al. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH consensus criteria. Blood 2011; 118: 4242\u20134249.","journal-title":"Blood"},{"key":"BFbmt201370_CR6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3324\/haematol.2011.055186","volume":"97","author":"J Pidala","year":"2012","unstructured":"Pidala J, Vogelsang G, Martin P, Chai X, Storer B, Pavletic S et al. Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study. Haematologica 2012; 97: 451\u2013458.","journal-title":"Haematologica"},{"key":"BFbmt201370_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/bmt.2009.238","volume":"45","author":"SA Mitchell","year":"2010","unstructured":"Mitchell SA, Leidy NK, Mooney KH, Dudley WN, Beck SL, LaStayo PC et al. Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Bone Marrow Transplant 2010; 45: 762\u2013769.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201370_CR8","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic SCT. Blood 2005; 106: 2912\u20132919.","journal-title":"Blood"},{"key":"BFbmt201370_CR9","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1200\/JCO.2006.09.7865","volume":"25","author":"ML Sorror","year":"2007","unstructured":"Sorror ML, Sandmaier BM, Storer BE, Maris MB, Baron F, Maloney DG et al. Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. J Clin Oncol 2007; 25: 4246\u20134254.","journal-title":"J Clin Oncol"},{"key":"BFbmt201370_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/bmt.2009.236","volume":"45","author":"ZY Lim","year":"2010","unstructured":"Lim ZY, Ingram W, Brand R, Ho A, Kenyon M, Devereux S et al. Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML. Bone Marrow Transplant 2010; 45: 633\u2013639.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201370_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1182\/blood-2007-07-098483","volume":"111","author":"ML Sorror","year":"2008","unstructured":"Sorror ML, Storer BE, Maloney DG, Sandmaier BM, Martin PJ, Storb R . Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia. Blood 2008; 111: 446\u2013452.","journal-title":"Blood"},{"key":"BFbmt201370_CR12","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/leu.2009.1","volume":"23","author":"L Farina","year":"2009","unstructured":"Farina L, Bruno B, Patriarca F, Spina F, Sorasio R, Morelli M et al. The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation. Leukemia 2009; 23: 1131\u20131138.","journal-title":"Leukemia"},{"key":"BFbmt201370_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbmt.2008.11.023","volume":"15","author":"SM Pollack","year":"2009","unstructured":"Pollack SM, Steinberg SM, Odom J, Dean RM, Fowler DH, Bishop MR . Assessment of the hematopoietic cell transplantation comorbidity index in Non-Hodgkin Lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009; 15: 223\u2013230.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201370_CR14","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/01.phm.0000223220.91914.61","volume":"85","author":"DL Groll","year":"2006","unstructured":"Groll DL, Heyland DK, Caeser M, Wright JG . Assessment of long-term physical function in acute respiratory distress syndrome (ARDS) patients: comparison of the Charlson Comorbidity Index and the Functional Comorbidity Index. Am J Phys Med Rehabil 2006; 85: 574\u2013581.","journal-title":"Am J Phys Med Rehabil"},{"key":"BFbmt201370_CR15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jclinepi.2004.10.018","volume":"58","author":"DL Groll","year":"2005","unstructured":"Groll DL, To T, Bombardier C, Wright JG . The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 2005; 58: 595\u2013602.","journal-title":"J Clin Epidemiol"},{"key":"BFbmt201370_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF02295996","volume":"12","author":"Q McNemar","year":"1947","unstructured":"McNemar Q . Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 1947; 12: 153\u2013157.","journal-title":"Psychometrika"},{"key":"BFbmt201370_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1164\/rccm.200502-212OC","volume":"172","author":"T Parimon","year":"2005","unstructured":"Parimon T, Madtes DK, Au DH, Clark JG, Chien JW . Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med 2005; 172: 384\u2013390.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFbmt201370_CR18","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.bbmt.2011.10.026","volume":"17","author":"ML Sorror","year":"2011","unstructured":"Sorror ML . Comorbidities and outcomes: advancing the field comes at a price. Biol Blood Marrow Transplant 2011; 17: 1721\u20131723.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201370_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11136-008-9413-7","volume":"18","author":"KN Lohr","year":"2009","unstructured":"Lohr KN, Zebrack BJ . Using patient-reported outcomes in clinical practice: challenges and opportunities. Qual Life Res 2009; 18: 99\u2013107.","journal-title":"Qual Life Res"},{"key":"BFbmt201370_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1470-2045(08)70195-5","volume":"9","author":"LW Jones","year":"2008","unstructured":"Jones LW, Eves ND, Haykowsky M, Joy AA, Douglas PS . Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol 2008; 9: 757\u2013765.","journal-title":"Lancet Oncol"},{"key":"BFbmt201370_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1474-9726.2009.00489.x","volume":"8","author":"Y Liu","year":"2009","unstructured":"Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, Ibrahim JG et al. Expression of p16INK4a in peripheral blood T-cells is a biomarker of human aging. Aging Cell 2009; 8: 439\u2013448.","journal-title":"Aging Cell"},{"key":"BFbmt201370_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.bbmt.2011.10.014","volume":"18","author":"WA Wood","year":"2012","unstructured":"Wood WA, Abernethy AP, Giralt S . Pretransplantation assessments and symptom profiles: predicting transplantation-related toxicity and improving patient-centered outcomes. Biol Blood Marrow Transplant 2012; 18: 497\u2013504.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201370","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T17:21:18Z","timestamp":1648056078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,13]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["BFbmt201370"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2013.70","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,13]]},"assertion":[{"value":"21 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}